{beta}-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma
Background
Although immunotherapy has revolutionized cancer treatment, hepatocellular carcinoma (HCC) continues to demonstrate limited clinical responses, highlighting the urgent need for novel immunomodulatory strategies. Trained immunity, an emergin…